ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

The Future is Small: Nanotechnology promises big changes for head and neck surgery

by Neil Canavan • September 2, 2011

  • Tweet
  • Email
Print-Friendly Version

You Might Also Like

  • Academic Head and Neck Surgery: Educating Our Future
  • Robotics for Head and Neck Surgery: The Wave of the Future?
  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?
  • A Better Look: Emerging imaging technologies show promise in fighting head and neck tumors
Explore This Issue
September 2011
Computer artwork of a carbon nanotube (tube, center) that has had different functional groups (groups of atoms that are responsible for a molecule’s chemical behavior) grafted onto its surface.

The biggest gains in the future for surgical and therapeutic treatments of head and neck cancer will likely include the use of imaging techniques, radio-enhancers and drug delivery vehicles that are really, really small.

The first nanostructure, the “buckyball,” was created in 1985 from just 60 carbon atoms; elongated carbon nanotubes, which quickly found a place in composite materials, soon followed. In medicine, taking a cue from the hollow buckyball construct, the drug Doxil was created in 1995 by loading the chemotherapeutic doxorubicin within a lipid nanoparticle. To get an idea of nanomedicine’s scale, consider the fact that mammalian cells are typically 2,000-10,000 nm, and cellular organelles range from 100 to 300 nm, while nanoparticles are often 50 nm or less.

Surgeon and nanotechnologist Ivan El-Sayed, MD, associate professor in the department of otolaryngology-head and neck surgery at the University of California-San Francisco, just published a review of the topic as it relates to gold nanoparticles (Curr Oncol Rep. 2010;12(2):121-128). Dr. El-Sayed’s interest focuses on several potential applications, imaging in particular, and the nanoparticles in question are indeed made of gold. “Gold is very interesting because it has extraordinary optical properties,” he explained; it is able to scatter or absorb light, and, critically, both of these phenomena can be detected and are capable of providing in vivo information. Further, gold absorbs different wavelengths of light that, depending on the wavelength, may result in the particles giving off heat to the surrounding tissue or even ionizing radiation.

So what does this mean for head and neck cancer patients? The applications include tissue imaging, photothermal ablation of tissues surrounding a gold nanoparticle, radiation enhancement and drug delivery (an ability inherent to the scale of nanomaterials in general).

Taken in reverse order: A tumor-targeted gold particle coated with tumor necrosis factor alpha is currently the subject of a phase I clinical trial. For radiotherapy, due to gold’s absorption properties, “we could actually reduce the dose of radiation that we have to give to the patient,” Dr. El-Sayed said, “but still have effect at the tumor site, meaning that we might be able to re-radiate down the road.” Photothermal ablation of tissue is also a possibility, with the potential to overcome tumor drug resistance when used with chemotherapy.

Pages: 1 2 3 | Single Page

Filed Under: Head and Neck, Tech Talk Tagged With: cancer, head and neck surgery, technologyIssue: September 2011

You Might Also Like:

  • Academic Head and Neck Surgery: Educating Our Future
  • Robotics for Head and Neck Surgery: The Wave of the Future?
  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?
  • A Better Look: Emerging imaging technologies show promise in fighting head and neck tumors

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.